Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Regulators and pharma to join forces on drug safety monitoring

September 28, 2007 Sales and Marketing reg, safety

Regulators, the pharma industry and academic institutions are to come together in a new global alliance to research drug side-effects. …
News

News roundup from Datamonitor

September 26, 2007 Sales and Marketing

Alnylam and Merck end collaborationBiopharmaceutical company Alnylam Pharmaceuticals and Merck & Co. have mutually agreed to terminate their July 2006 …
News

Global products for local people: tailoring your brand strategy

September 25, 2007 Medical Communications, Sales and Marketing branding, global

Deciding which aspects of a global brand should be defined centrally and how much freedom there is in any given …
Feature

European approval for GSK’s cancer vaccine

September 25, 2007 Sales and Marketing

GlaxoSmithKline's cervical cancer vaccine Cervarix has been approved in Europe, setting it up for a head-to-head clash with Sanofi-Pasteur MSD's …
News

Pfizer’s Celsentri approved in Europe

September 25, 2007 Research and Development, Sales and Marketing HIV

Pfizer's Celsentri has been approved in Europe, making it the first in a new, oral class of HIV drugs in …
News

Takeda claims safety advantages for Actos

September 20, 2007 Sales and Marketing

Takeda says new data on its diabetes drug Actos shows a number of safety advantages over GSK's rival product Avandia.Two …
News

Clinton unveils plans for universal healthcare

September 19, 2007 Sales and Marketing

Hilary Clinton has unveiled plans to introduce universal healthcare insurance in America as part of her campaign to become US …
News

Latest news from Datamonitor

September 17, 2007 Research and Development, Sales and Marketing

Cell Therapeutics launches Phase III study for pixantroneCell Therapeutics has launched its phase III clinical trial, known as PIX303, of …
News

NICE approves MSD and Schering-Plough’s Ezetrol

September 14, 2007 Sales and Marketing Inegy, NICE, cv

NICE has approved Merck Sharp & Dohme and Schering-Plough's Ezetrol, but recommended the cheapest version be used – effectively blocking …
News

Novartis launches Cubicin for MRSA

September 14, 2007 Sales and Marketing

Novartis has launched Cubicin – its novel, first-in-class antibiotic – in the UK, in a new indication to treat the …
News

AstraZeneca looks to outflank cholesterol competitors

September 14, 2007 Sales and Marketing

AstraZeneca is to conduct a head-to-head trial of Crestor against rival treatment Vytorin in the hugely competitive cholesterol treatment market.The …
News

BMS outsources safety monitoring to India

September 14, 2007 Sales and Marketing India, safety

A team of 140 people based in Chennai, India, is to help Bristol-Myers Squibb monitor safety and side-effect reports from …
News

Boehringer bids for oncology presence with lung cancer treatment

September 10, 2007 Sales and Marketing

A novel treatment for lung cancer which could help patients who develop resistance to other drugs is being developed by …
News

How can customer insight work for you?

September 10, 2007 Sales and Marketing customers, insight, sales

It should be a very simple equation: if you can understand what motivates clinicians – and all the other prescribing …
Feature

Latest news from Datamonitor

September 10, 2007 Research and Development, Sales and Marketing

Akela reports positive results for Fentanyl Taifun trialAkela Pharma has reported promising results from a phase IIb trial for its …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026